MGI Tech 10th Anniversary
Ten years advancing genomics
Ten years in, the results speak for themselves — built on steady progress, practical innovation, and strong global partnerships. Join us as we celebrate the key moments, milestones, and breakthroughs that have shaped MGI Tech’s journey so far, while laying the foundation for what comes next. Over the past decade, MGI Tech has grown from a bold idea into a recognised global player in genomic technology. This milestone marks ten years of continuous development — from early platform innovation to delivering high-throughput sequencing solutions used by researchers, clinicians, and institutions around the world.
These achievements reflect meaningful progress not only in technology itself, but in how sequencing is applied in real-world settings. By improving accessibility, reducing costs, and advancing performance at scale, MGI Tech has helped bring genomics closer to everyday use across research, clinical practice, and beyond.
Defining Moments in Sequencing Innovation
Desktop sequencing becomes practical
The introduction of the G50 and G400 marked a shift towards compact, bench-top sequencers that combined power with flexibility. These systems made high-quality sequencing more accessible for everyday laboratory use, supporting applications such as cancer research and transcriptomics without the need for large, complex infrastructure.
Sequencing goes industrial
The launch of the T7 platform signalled a move into true industrial-scale sequencing. With the ability to generate massive volumes of data daily, it enabled national genome programmes to operate faster and more cost-effectively, supporting large population studies across multiple countries.
Portable sequencing takes off
A new wave of compact and efficient sequencers, including the E25 and G99, brought speed and portability to the forefront. These systems allowed faster turnaround times for diagnostics and proved capable of operating in extreme environments, opening up field-based research in areas like biodiversity and infectious disease monitoring.
The $100 genome becomes a reality
Advances in cost efficiency pushed whole-genome sequencing below the $100 mark, making large-scale genomic projects far more viable. Platforms like the T20×2 enabled high-volume sequencing at low cost, accelerating the adoption of genomics in population studies and moving precision medicine closer to routine clinical use.
AI and the future
Artificial intelligence is becoming embedded within sequencing workflows, simplifying analysis and improving accuracy. At the same time, the industry is moving towards integrated platforms that combine short-read, long-read, and spatial technologies. This shift points towards more flexible, scalable systems and a future where genomics is fully embedded in everyday healthcare, with costs continuing to fall.
